BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27150510)

  • 61. Exploring the substrate specificities of alpha-2,6- and alpha-2,3-sialyltransferases using synthetic acceptor analogues.
    Van Dorst JA; Tikkanen JM; Krezdorn CH; Streiff MB; Berger EG; Van Kuik JA; Kamerling JP; Vliegenthart JF
    Eur J Biochem; 1996 Dec; 242(3):674-81. PubMed ID: 9022696
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Redox-Controlled Site-Specific α2-6-Sialylation.
    Lu N; Ye J; Cheng J; Sasmal A; Liu CC; Yao W; Yan J; Khan N; Yi W; Varki A; Cao H
    J Am Chem Soc; 2019 Mar; 141(11):4547-4552. PubMed ID: 30843692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
    Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
    Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enzymatic synthesis of unique sialyloligosaccharides using marine bacterial alpha-(2-->3)- and alpha-(2-->6)-sialyltransferases.
    Mine T; Miyazaki T; Kajiwara H; Naito K; Ajisaka K; Yamamoto T
    Carbohydr Res; 2010 Jul; 345(10):1417-21. PubMed ID: 20413108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression.
    Jeong YT; Choi O; Lim HR; Son YD; Kim HJ; Kim JH
    J Microbiol Biotechnol; 2008 Dec; 18(12):1945-52. PubMed ID: 19131698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of membrane lipids on the lactosylceramide molecular species specificity of CMP-N-acetylneuraminate:lactosylceramide sialyltransferase.
    Kadowaki H; Grant MA; Williams LA
    J Lipid Res; 1993 Jun; 34(6):905-14. PubMed ID: 8354956
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases.
    Uslupehlivan M; Şener E; İzzetoğlu S
    Carbohydr Res; 2019 Dec; 486():107823. PubMed ID: 31557542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
    Chiricolo M; Malagolini N; Bonfiglioli S; Dall'Olio F
    Glycobiology; 2006 Feb; 16(2):146-54. PubMed ID: 16192407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Purification and characterization of an endogenous inhibitor of the sialyltransferase CMP-N-acetylneuraminate: lactosylceramide alpha 2,6-N-acetylneuraminyltransferase (EC 2.4.99.-).
    Albarracin I; Lassaga FE; Caputto R
    Biochem J; 1988 Sep; 254(2):559-65. PubMed ID: 2460092
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship of membrane phospholipid composition, lactosylceramide molecular species, and the specificity of CMP-N-acetylneuraminate:lactosylceramide alpha 2,3-sialyltransferase to the molecular species composition of GM3 ganglioside.
    Kadowaki H; Grant MA
    J Lipid Res; 1995 Jun; 36(6):1274-82. PubMed ID: 7666005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
    Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
    Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
    Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
    J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Crystal structure of Vibrionaceae Photobacterium sp. JT-ISH-224 alpha2,6-sialyltransferase in a ternary complex with donor product CMP and acceptor substrate lactose: catalytic mechanism and substrate recognition.
    Kakuta Y; Okino N; Kajiwara H; Ichikawa M; Takakura Y; Ito M; Yamamoto T
    Glycobiology; 2008 Jan; 18(1):66-73. PubMed ID: 17962295
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies on the inhibition of sialyl- and galactosyltransferases.
    Kleineidam RG; Schmelter T; Schwarz RT; Schauer R
    Glycoconj J; 1997 Jan; 14(1):57-66. PubMed ID: 9076514
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enzymatic characterization of beta D-galactoside alpha2 leads to 3 sialyltransferase from porcine submaxillary gland.
    Rearick JI; Sadler JE; Paulson JC; Hill RL
    J Biol Chem; 1979 Jun; 254(11):4444-51. PubMed ID: 438198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
    Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
    J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroPlate Sialyltransferase Assay: A Rapid and Sensitive Assay Based on an Unnatural Sialic Acid Donor and Bioorthogonal Chemistry.
    Noel M; Gilormini PA; Cogez V; Lion C; Biot C; Harduin-Lepers A; Guérardel Y
    Bioconjug Chem; 2018 Oct; 29(10):3377-3384. PubMed ID: 30192128
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transcriptional induction of beta-galactoside alpha-2,6-sialyltransferase in rat fibroblast by dexamethasone.
    Vandamme V; Pierce A; Verbert A; Delannoy P
    Eur J Biochem; 1993 Jan; 211(1-2):135-40. PubMed ID: 7678804
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
    Souady J; Hülsewig M; Distler U; Haier J; Denz A; Pilarsky C; Senninger N; Dreisewerd K; Peter-Katalinic J; Müthing J
    Glycobiology; 2011 May; 21(5):584-94. PubMed ID: 21147760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of amino acid substitutions in the sialylmotifs on molecular expression and enzymatic activities of α2,8-sialyltransferases ST8Sia-I and ST8Sia-VI.
    Takashima S; Matsumoto T; Tsujimoto M; Tsuji S
    Glycobiology; 2013 May; 23(5):603-12. PubMed ID: 23315426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.